Simultaneous detection of co-segregating missense mutations of the Toll-like receptor 4

BioTechniques

Volumn 33, Issue 4, 2002, Pages 748-754

  Hsieh, K ^a   Endler, G ^a   Lalouschek, W ^a   Haering, D ^a   Mannhalter, Christine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; NUCLEOTIDE; TOLL LIKE RECEPTOR 4;

ARTICLE; ATHEROSCLEROSIS; GEL ELECTROPHORESIS; GENE SEQUENCE; GENETIC CODE; GENETIC REGULATION; GENOTYPE; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNE SYSTEM; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; DROSOPHILA PROTEINS; FEMALE; GENE FREQUENCY; HUMANS; IMMUNE TOLERANCE; LINKAGE DISEQUILIBRIUM; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0036793256     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Arbour, N.C., E. Lorenz, B.C. Schutte, J. Zabner, J.N. Kline, M. Jones, K. Frees, J.L. Watt, and D.A. Schwartz. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25:187-191.
2. Beutler, B., I.W. Milsark, and A.C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871.
3. Coutinho, A., L. Forni, F. Melchers, and T. Watanabe. 1977. Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide. Eur. J. Immunol. 7:325-328.
4. Janeway, C.A., Jr. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13:11-16.
5. Lorenz, E., K.L. Frees, and D.A. Schwartz. 2001. Determination of the TLR4 genotype using allele-specific PCR. BioTechniques 31:22-24.
6. Lorenz, E., D.A. Schwartz, P.J. Martin, T. Gooley, M.T. Lin, J.W. Chien, J.A. Hansen, and J.G. Clark. 2001. Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant 7:384-387.
7. Poltorak, A., X. He, I. Smirnova, M.Y. Liu, C.V. Huffel, X. Du, D. Birdwell, E. Alejos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088.
8. Read, R.C., J. Pullin, S. Gregory, R. Borrow, E.B. Kaczmarski, F.S. di Giovine, S.K. Dower, C. Cannings, et al. 2001. A functional polymorphism of Toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J. Infect. Dis. 184:640-642.
9. Sultzer, B.M. 1968. Genetic control of leucocyte responses to endotoxin. Nature 219:1253-1254.
10. The Vienna Stroke Study Group. 2001. The Vienna Stroke Registry-objectives and methodology. J. Mid. Eur. Med. 113:141-147.
11. Tracey, K.J., B. Beutler, S.F. Lowry, J. Merryweather, S. Wolpe, I.W. Milsark, R.J. Hariri, T.J. Fahey, III, et al. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
12. Xu, X.H., P.K. Shah, E. Faure, O. Equils, L. Thomas, M.C. Fishbein, D. Luthringer, X.P. Xu, et al. 2001. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104:3103-3108.